Clinical Study

Gabapentin versus Transdermal Fentanyl Matrix for the Alleviation of Chronic Neuropathic Pain of Radicular Origin: A Randomized Blind Multicentered Parallel-Group Noninferiority Trial

Table 1

Drug administration schedule for the present study.

Day1–67–2829–56

Fentanyl12 mcg/hPain was assessed every six days. The dose was increased gradually by 12 mcg/h when the mean NRS was higher than 2.The last dose was maintained
Day123–45–67–2829–56
Gabapentin300 mg hs300 mg bid300 mg tidMorning: 300 mg, afternoon: 300 mg, evening: 600 mgPain was assessed every six days. The dose was increased gradually by 300 mg/day up to 2400 mg/day when the mean NRS was higher than 2.The last dose was maintained